Sunday, September 23, 2018

Popular Articles

HQ Capital names former Park Madison principle as business development director

HQ Capital has appointed Amy Thiessen as director of business development in North America.

Rothschild & Co closes first US PE fund on $655m

Rothschild & Co’s investment arm has reached a $655m final close for Five Arrows Capital Partners, its first corporate private equity vehicle for the US.

Inflexion bags 50% IRR on Outdoor Plus sale

Inflexion Private Equity has secured a 50 per cent IRR through the exit of its minority stake in Outdoor Plus, in a sale to Global radio.

Vista’s Fund V, Fund VI exit Marketo to Adobe for $4.75bn

Vista Equity Partners is set to exit its software business Marketo in a sale to tech major Adobe for $4.75bn.

Emerging infra boost possible from national project preparation facilities – and IFIs can help

Emerging market governments can boost infrastructure investment activity by developing more national project preparation facilities, EBRD infra policy head Matthew Jordan Tank has told AltAssets.

CVC taps Asia Fund IV to pick up majority stake in UnitedLex

CVC Capital Partners has used its Asia Fund IV to acquire a majority stake in legal services business UnitedLex.

Tikehau Capital in talks to buy €4.8bn-managing real estate firm Sofidy

French asset management major Tikehau Capital is in talks to buy €4.8bn-managing real estate investor Sofidy.

Riverside returns to New Zealand for Hiway buyout, five months after first exit in...

The Riverside Company has bought into New Zealand-based road, rail and pavement stabilisation recycling specialist Hiway.

Lone Star said to eye Xella IPO, less than two years after €2.2bn buyout

Distressed assets private equity specialist Lone Star is reportedly eyeing a stock market listing for German building materials business Xella, less than two years after its €2.2bn buyout of the company.

Vulnerable people healthcare VC newcomer Town Hall hits target-busting fund close in just four...

A new venture capital house focusing on the healthcare needs of vulnerable people has smashed its target to close its debut fund after just four months in the market.

Get the latest PE News & Research delivered to your inbox every morning